Keyshawn Davis now only has a suspension to show for his toughest test to date.

The 2020 Olympic Silver medalist and rising lightweight produced a positive drug test for marijuana surrounding his October 14 fight versus Nahir Albright at Fort Bend Epicenter in Rosenberg, Texas. While deemed a recreational drug and legal in most states, it remains illegal in Texas which forced the Texas Department of Licensing and Regulation (TDLR) to issue a 90-day suspension and change his majority win to a No-Contest.

BoxRec.com’s Grey Johnson was the first to report the result change and Davis’ suspension. TDLR officials were able to confirm the suspension to BoxingScene.com, but not the specifics due to HIPAA law and merely classified the disciplinary action as a "rules violation."

Top Rank officials did not respond to multiple inquiries from Boxing Scene seeking confirmation.

While many have scoffed at the relatively brief ban, it’s just long enough to ruin plans for the unbeaten Davis (9-0, 6KOs; 1NC), who was due to appear on the December 9 ESPN card from Charles F. Dodge City Center in Pembroke Pines, Florida. Top Rank has hosted a boxing event immediately following the network’s Heisman Trophy presentation every year since first entering its ESPN output deal in 2017.

Davis appeared on the 2021 and 2022 editions but will have to sit out this year’s show. Even with the suspension backdated to October 14—the date of the positive drug test—Davis cannot return to the ring until next January 14 as the disciplinary action has to be honored by all U.S. jurisdictions under the Association of Boxing Commissions (ABC).

The 90-day ban is commonplace for TDLR regarding any drug testing-related incident. Former title challenger Chris Arreola was hit with the same disciplinary action after he tested positive for marijuana for his December 2015 bout versus Travis Kauffman in San Antonio.

Mexico’s Alejandra Jimenez was issued a 90-day temporary suspension while an investigation was underway when she tested positive for the banned substance Stanazol. The development impacted her January 2020 unified WBC/WBO super middleweight title win over Franchon Crews-Dezurn. The split decision was downgraded to a No-Contest and both belts were eventually returned to Crews-Dezurn.

Jake Donovan is a senior writer for BoxingScene.com. Twitter: @JakeNDaBox